How do you pay?

How to pay the least

Ask for the cash price

Lisraya

We didn’t find one.

  1. Ask your pharmacy for Lisraya’s cash price, and one or two other pharmacies too.
  2. Lisraya’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameLisraya
Authorized genericbrepocitinib
Regular genericbrepocitinib
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Lisraya?
The original
–
–

Brand nameThe maker’s card

My Compass Support Copay Savings Program

Savings card from Priovant Therapeutics

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Sign up on lisraya.com 

In the maker’s words

“You may be eligible to pay as little as $0 per month for LISRAYA…”

From the maker’s offer on lisraya.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Lisraya itself, from the same company, sold without the brand name, and usually for less. For now Lisraya is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

LISRAYA is a Janus kinase (JAK) and tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of dermatomyositis in adult patients.

Limitations of Use LISRAYA is not recommended for use in combination with other JAK inhibitors, other TYK2 inhibitors, or biologic DMARDs.

Source: the FDA label for Lisraya (Priovant Therapeutics, Inc.), August 28, 2026. Full label on DailyMed 

Good to know